Ebru Uz
Impact in
- Nephrology top 1%
- Gout, Hyperuricemia, Uric Acid
- Parathyroid Disorders and Treatments
-
- Nigella sativa pharmacological applications
Papers in
-
- Gout, Hyperuricemia, Uric Acid 2
-
- Chemotherapy-induced organ toxicity mitigation 4
- Co-authors
- Ali Akçay (17 shared papers)Faruk Turğut (15 shared papers)Mehmet Kanbay (12 shared papers)Nüket Bavbek (15 shared papers)Adrian Covic (4 shared papers)Bünyamin Işık (3 shared papers)Adem Özkara (4 shared papers)Yusuf Selçoki (3 shared papers)
- Journals
- Renal Failure (6 papers)American Journal of Nephrology (2 papers)British Journal of Ophthalmology (1 paper)Peritoneal Dialysis International (1 paper)Toxicology and Industrial Health (1 paper)
- Partner nations
- TürkiyeUnited StatesRomania
In The Last Decade
Ebru Uz
29 papers receiving 982 citations
Peers
Comparison fields: 5 of 92
- Nephrology 375
- Complementary and alternative medicine 133
- Toxicology 39
- Pharmacology 93
- Pathology and Forensic Medicine 172
Countries citing papers authored by Ebru Uz
This map shows the geographic impact of Ebru Uz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebru Uz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebru Uz more than expected).
Fields of papers citing papers by Ebru Uz
This network shows the impact of papers produced by Ebru Uz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebru Uz. The network helps show where Ebru Uz may publish in the future.
Co-authors
The 25 scholars most cited alongside Ebru Uz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 263 | |
| 2 | 2008 | 133 | |
| 3 | 2008 | 96 | |
| 4 | 2008 | 77 | |
| 5 | 2005 | 66 | |
| 6 | 2008 | 64 | |
| 7 | 2008 | 38 | |
| 8 | 2007 | 33 | |
| 9 | 2009 | 30 | |
| 10 | 2007 | 28 | |
| 11 | 2007 | 28 | |
| 12 | 2008 | 27 | |
| 13 | 2007 | 24 | |
| 14 | 2006 | 23 | |
| 15 | 2007 | 20 | |
| 16 | 2007 | 19 | |
| 17 | 2008 | 13 | |
| 18 | 2011 | 12 | |
| 19 | 2009 | 11 | |
| 20 | 2016 | 11 |
About Ebru Uz
Ebru Uz is a scholar working on Nephrology, Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health, Pharmacology and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (4 papers), Adenosine and Purinergic Signaling (2 papers), Gastrointestinal motility and disorders (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Gout, Hyperuricemia, Uric Acid (2 papers), Pediatric Urology and Nephrology Studies (2 papers), Pregnancy and Medication Impact (2 papers) and Nigella sativa pharmacological applications (2 papers). The work is most often cited by research in Nephrology (375 citations), Complementary and alternative medicine (133 citations), Toxicology (39 citations), Pharmacology (93 citations) and Pathology and Forensic Medicine (172 citations). Ebru Uz has collaborated with scholars based in Türkiye, United States and Romania. Frequent co-authors include Ali Akçay, Faruk Turğut, Mehmet Kanbay, Nüket Bavbek, Adrian Covic, Bünyamin Işık, Adem Özkara, Yusuf Selçoki, Ramazan Yiğitoğlu and Arif Kaya. Their work appears in journals such as Renal Failure, American Journal of Nephrology, British Journal of Ophthalmology, Peritoneal Dialysis International and Toxicology and Industrial Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.